12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Other News

Innovimmune autoimmune, inflammation news

Newco Innovimmune received a $600,000 Advanced Technology Small Business Innovation Research (SBIR) grant from NIH to develop the company's INV-88 product portfolio of oral small molecule macrophage migration inhibitory...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >